Citadel Advisors’s GMO Systematic Investment Grade Credit ETF INVG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,065
Closed -$256K – 15678
2026
Q2
$256K Sell
10,065
-3,000
-23% -$76.3K ﹤0.01% 11488
2026
Q1
$330K Buy
+13,065
New +$335K ﹤0.01% 10265
2025
Q4
– Sell
-15,551
Closed -$402K – 14625
2025
Q3
$402K Sell
15,551
-2,723
-15% -$69.8K ﹤0.01% 9659
2025
Q2
$467K Buy
+18,274
New +$462K ﹤0.01% 8792

Other funds holding INVG

Citadel Advisors's INVG Position: Q3 2026 in Review

Citadel Advisors sold out of GMO Systematic Investment Grade Credit ETF (INVG) in Q3 2026, closing a stake of 10,065 shares — an estimated $256K sold.

Citadel Advisors first reported a position in INVG in Q2 2025 and held it in 4 quarters. The position peaked at $467K in Q2 2025. 5 funds tracked by Wall St. Rank hold INVG as of Q3 2026.

  • Citadel Advisors reported no remaining GMO Systematic Investment Grade Credit ETF position as of Q3 2026 after selling out during the quarter.
  • Citadel Advisors sold 10,065 GMO Systematic Investment Grade Credit ETF shares in Q3 2026, an estimated $256K.
  • Citadel Advisors first reported a position in GMO Systematic Investment Grade Credit ETF in Q2 2025 and held it in 4 quarters.
  • Citadel Advisors's GMO Systematic Investment Grade Credit ETF position peaked at $467K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held GMO Systematic Investment Grade Credit ETF as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.